Merck

Merck (MRK) Net Profit And Net Margin From 2012 To 2016

This report provides the last five years net profit and net margin of Merck & Co., Inc. (MRK) from 2012 to 2016. Merck reported a total net income of $3.9 billion during 2016. Merck generated a total of $39.8 billion revenues during 2016. Merck net profit margin was 9.8% during 2016. The net profit and the net profit margin correspond to the fiscal year ending in December.

Merck (MRK) Research & Development (R&D) Spending Analysis From 2012 To 2016

This report provides the last five years research and development (R&D) expenses of Merck & Co., Inc. (MRK) from 2012 to 2016. Merck spent a total of $10.1 billion on research and development (R&D) activities during 2016. Merck generated a total of $39.8 billion revenues during 2016. As a percentage of revenues, Merck spent 25.4% of its total revenues on R&D activities during 2016. The R&D spending numbers are for the fiscal year ending in December.

Merck (MRK) Business Analysis – Analyze Historical Performance, Strategic Priorities, And Business Improvement Opportunities...

Merck & Co., Inc. with $40 billion revenues in the year 2016 was the number 3 Pharmaceuticals company. Read this report to know the top competitors of Merck and identify growth and cost optimization opportunities of Merck

Merck (MRK) Revenues And Revenue Growth From 2012 To 2016

This report provides the last five years revenues and revenue growth of Merck & Co., Inc. (MRK) from 2012 to 2016. Merck generated a total of $39.8 billion revenues during 2016. Merck reported a revenue growth of 0.8% year-over-year during 2016. The revenues and the revenue growth correspond to the fiscal year ending in December.

Merck (MRK) Sales, Marketing, General & Administrative (SG&A) Spending Analysis From 2012 To 2016

This report provides the last five years sales, marketing, general & administrative (SG&A) expenses of Merck & Co., Inc. (MRK) from 2012 to 2016. Merck spent a total of $9.8 billion on sales, marketing, general, and administrative (SG&A) activities during 2016. Merck generated a total of $39.8 billion revenues during 2016. As a percentage of revenues, Merck spent 24.5% of its total revenues on SG&A activities during 2016. The SG&A spending numbers are for the fiscal year ending in December.

Merck (MRK) Cost of Sales (COGS) Analysis From 2012 To 2016

This report provides the last five years cost of sales (COGS) analysis of Merck & Co., Inc. (MRK) from 2012 to 2016. Merck spent a total of $13.9 billion on COGS during 2016. Merck generated a total of $39.8 billion revenues during 2016. As a percentage of revenues, Merck spent 34.9% of its total revenues on COGS during 2016. The cost of sales (COGS) numbers are for the fiscal year ending in December.

Merck (MRK) Accounts Payable (A/P) Analysis From 2012 To 2016

This report provides the last five years Accounts Payable (A/P) analysis of Merck & Co., Inc. (MRK) from 2012 to 2016. Merck invested a total of $4.1 billion on accounts payable during 2016. Merck generated a total of $39.8 billion revenues during 2016. As a percentage of revenues, Merck invested 10.4% of its total revenues on accounts payable activities during 2016. The accounts payable numbers are for the fiscal year ending in December.

Merck (MRK) Accounts Receivable (A/R) Analysis From 2012 To 2016

This report provides the last five years Accounts Receivable (A/R) analysis of Merck & Co., Inc. (MRK) from 2012 to 2016. Merck invested a total of $7 billion on accounts receivable during 2016. Merck generated a total of $39.8 billion revenues during 2016. As a percentage of revenues, Merck invested 17.6% of its total revenues on accounts receivable during 2016. The accounts receivable numbers are for the fiscal year ending in December.

Merck (MRK) Inventory Spending Analysis From 2012 To 2016

This report provides the last five years inventory spending analysis of Merck & Co., Inc. (MRK) from 2012 to 2016. Merck invested a total of $4.9 billion on inventories during 2016. Merck generated a total of $39.8 billion revenues during 2016. As a percentage of revenues, Merck invested 12.2% of its total revenues on inventories during 2016. The inventory numbers are for the fiscal year ending in December.

Merck (MRK) Property, Plant & Equipment (PP&E) Investment Analysis From 2012 To 2016

This report provides the last five years property, plant & equipment (PP&E) investment analysis of Merck & Co., Inc. (MRK) from 2012 to 2016. Merck invested a total of $12 billion on property, plant & equipment (PP&E) activities during 2016. Merck generated a total of $39.8 billion revenues during 2016. As a percentage of revenues, Merck invested 30.2% of its total revenues on PP&E activities during 2016. The PP&E investment numbers are for the fiscal year ending in December.